- Job seekers
- About UCB India
- Drug Safety
We have a shared ambition to transform the lives of people living with severe diseases. We focus on central nervous system and immunology disorders – putting patients at the center of our world.
A global biopharmacetical company focused on severe diseases with operations in approximately 40 countries and a global revenue of €3.88 billion in 2015.
We combine biology and chemistry to achieve major breakthroughs. By integrating our expertise in large, antibody-based molecules and small, chemically-derived molecules, we can offer patients with severe diseases, their families and specialist physicians the advantages of both the molecules to produce extraordinary breakthroughs.
We partner with the leaders in the pharmaceutical industry. The complexities of severe diseases are beyond the expertise and resources of a single organisation. That is why we have teamed up with over 30 partners - we play to our strengths and tap into the organisations with greater or complementary strengths.